Update to FDA’s Risk Evaluation and Mitigation Strategy for Mifepristone on Dec. 16, 2021, Eliminating In-Person Dispensing Requirement
FDA Lifts In-Person Dispensing Requirement for Mifepristone Abortion Pill.
Vol. 135 No. 8
Recent Guidance
SEC, Framework for “Investment Contract” Analysis of Digital Assets (2019)
SEC Provides Analytical Tools for Assessing Digital Assets.
Vol. 132 No. 8
Guidance on Administrative Law Judges After Lucia v. SEC (S. Ct.), July 2018
Solicitor General Issues Guidance On Administrative Judges.
Vol. 132 No. 3